신경 면역측정 시장 규모, 점유율, 성장 분석 : 제품 유형별, 기술별, 바이오마커 유형별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Neuro Immunoassay Market size was valued at USD 3.2 Billion in 2024 and is poised to grow from USD 3.42 Billion in 2025 to USD 5.88 Billion by 2033, growing at a CAGR of 7.0% during the forecast period (2026-2033).

The neuro immunoassay market focuses on assays that measure immune and neuronal biomarkers crucial for diagnosing central nervous system disorders. The increasing prevalence of neurodegenerative and neuroinflammatory diseases has heightened the demand for early and minimally invasive diagnostic tools. The evolution from single-analyte ELISAs to advanced multiplex platforms, including ultra-sensitive digital assays, has significantly improved detection capabilities for low-abundance analytes. This progress underscores the urgent clinical need driving investments from diagnostics firms and biopharma partners. Technological sensitivity is a key growth factor, enhancing assay performance and expanding applications. Notably, artificial intelligence plays a pivotal role by improving diagnostic accuracy, standardizing quality checks, and enabling quicker, more reliable clinical decisions, thereby propelling market growth and integration into routine care pathways.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neuro Immunoassay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neuro Immunoassay Market Segments Analysis

Global neuro immunoassay market is segmented by product type, technology, biomarker type, application, end-user and region. Based on product type, the market is segmented into Reagents And Kits and Analyzers. Based on technology, the market is segmented into Radioimmunoassays (RIA), Polymerase Chain Reaction (PCR), Enzyme-Linked Immunosorbent Assay (ELISA), Western Blot, Rapid Tests and Enzyme-Linked Immunospot Assay (ELISPOT). Based on biomarker type, the market is segmented into Amyloid-Beta (AB), Tau Protein (p-Tau), Alpha-Synuclein (a-syn), Neurofilament Light Chain (NfL), Autoantibodies, Cytokines, Glial Fibrillary Acidic Protein (GFAP), Neuron-Specific Enolase (NSE), Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) and Brain-Derived Neurotrophic Factor (BDNF). Based on application, the market is segmented into Alzheimer's Disease, Parkinson's Disease (PD), Huntington's Disease, Amyotrophic Lateral Sclerosis (ALS) and Spinal Muscular Atrophy (SMA). Based on end-user, the market is segmented into Hospitals, Clinics, Academic Organizations, Biopharmaceutical Companies, Pharmaceutical Companies and Other End-Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Neuro Immunoassay Market

The Global Neuro Immunoassay market is driven by significant advancements in assay sensitivity, specificity, and multiplexing capabilities, which enhance the detection of neuroimmune biomarkers across various sample types and disease conditions. These improvements facilitate earlier and more precise identification of neurological immune responses. Additionally, manufacturers are innovating reagent chemistry and detection platforms, boosting clinical confidence and expanding applications in both research and diagnostics. This technological evolution lowers usage barriers, promoting market growth by enabling the development of new assay formats and workflows tailored for neuroinflammatory and neurodegenerative research, ultimately leading to increased adoption among laboratories and clinicians.

Restraints in the Global Neuro Immunoassay Market

The Global Neuro Immunoassay market faces significant challenges due to the substantial investments needed for assay development, clinical validation, and adherence to regulatory standards. These financial and temporal barriers disproportionately impact smaller laboratories and emerging manufacturers, which often struggle to navigate lengthy development processes and certification requirements. As a result, competition is diminished, and the introduction of new products is delayed, limiting the availability of diverse neuro immunoassays in the market. This economic strain hinders rapid portfolio expansion and slows the integration of these diagnostic tools into clinical practices, despite a growing interest and demand for neuroimmune diagnostics among healthcare providers.

Market Trends of the Global Neuro Immunoassay Market

The Global Neuro Immunoassay market is witnessing a significant trend towards point-of-care expansion, with the adoption of these advanced diagnostic tools moving from central laboratories to clinics and community settings. This shift is primarily driven by the growing demand for timely and actionable biomarker information, which is essential for improving patient care and facilitating early treatment decisions. The development of simplified platforms and portable instruments enables clinicians to conduct tests closer to patients, effectively integrating these assessments into existing clinical workflows and electronic health records. Enhanced access to diagnostic services promotes collaboration across specialties and fuels innovation in user-friendly assays designed specifically for outpatient environments, positioning neuro immunoassays as a pivotal component in modern healthcare delivery.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Neuro Immunoassay Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Reagents And Kits
  • Enzyme Linked Immunosorbent Assay Reagents
  • Western Blotting Kits
  • Multiplex Assay Kits
• Analyzers
  • Automated Immunoassay Analysers
  • Point Of Care Immunoassay Analysers
  • High Throughput Immunoassay Analysers

Global Neuro Immunoassay Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Radioimmunoassays (RIA)
• Polymerase Chain Reaction (PCR)
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Western Blot
• Rapid Tests
• Enzyme-Linked Immunospot Assay (ELISPOT)

Global Neuro Immunoassay Market Size by Biomarker Type & CAGR (2026-2033)

• Market Overview
• Amyloid-Beta (AB)
• Tau Protein (p-Tau)
• Alpha-Synuclein (a-syn)
• Neurofilament Light Chain (NfL)
• Autoantibodies
• Cytokines
• Glial Fibrillary Acidic Protein (GFAP)
• Neuron-Specific Enolase (NSE)
• Ubiquitin C-Terminal Hydrolase L1 (UCH-L1)
• Brain-Derived Neurotrophic Factor (BDNF)

Global Neuro Immunoassay Market Size by Application & CAGR (2026-2033)

• Market Overview
• Alzheimer's Disease
• Parkinson's Disease (PD)
• Huntington's Disease
• Amyotrophic Lateral Sclerosis (ALS)
• Spinal Muscular Atrophy (SMA)

Global Neuro Immunoassay Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Clinics
• Academic Organizations
• Biopharmaceutical Companies
• Pharmaceutical Companies
• Other End-Users

Global Neuro Immunoassay Market Size & CAGR (2026-2033)

• North America (Product Type, Technology, Biomarker Type, Application, End-User)
  • US
  • Canada
• Europe (Product Type, Technology, Biomarker Type, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Biomarker Type, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Biomarker Type, Application, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Biomarker Type, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioLegend Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meso Scale Diagnostics LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sino Biological Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quanterix Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cusabio Technology LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OriGene Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elabscience Biotechnology Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RayBiotech Life Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enzo Life Sciences Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rockland Immunochemicals Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Assay Genie Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novus Biologicals LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MyBioSource Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immuno-Biological Laboratories Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boster Biological Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cloud-Clone Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FineTest Biotech Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbexa Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations